4 - Gynaecology Flashcards

1
Q

Steps for administering an intracervical block

A

2ml mepivicaine in dental syringe
Inject 0.2ml under skin of anterior lip at 12 o’clock
Apply tenaculum to anterior lip
Insert needle at 3 o’clock into external os - parallel to canal
Withdraw and inject 0.9 ml
Insert needle at 3 o’clock into external os - parallel to canal
Withdraw and inject 0.9 ml
Wait 2 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for HPV

A
Increased number of sexual partners
Persistent infection
Immunocompromise
Higher viral load
Cigarette smoking
Lower socio-economic status
Prolonged use of COCP
Higher number of pregnancies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How to protect against HPV infection

A

Condom use
Late first pregnancy
(Gardasil)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cell type of ectocervix

A

Non-keratinising stratified squamous epithelium

Resistant to low vaginal PH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cell type of endocervix

A

Mucin-secreting columnar epithelium

Undergoes squamous meta plasma when exposed to vaginal PH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the transformation zone of the cervix

A

Where columnar epithelium has undergone metaplasia to become squamous epithelium.
Area between old and new squamo-columnar junction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cytological feature of cervical dyskaryosis

A

Increased nuclear:cytoplasmic ratio
Mitotic figures
Nuclear pleomorphism
Nuclear hyperchromasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cytological features of cervical HPV infection

A

Koilocytosis
Hyperkeratosis
Multinucleation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Depth of changes in CIN1

A

Changes in basal 3rd of epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Depth of changes in CIN2

A

Basal 2/3 of epithelium

More marked nuclear atypia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Depth of changes in CIN3

A

Entire epithelium

More severe changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Incidence of endometriosis

A

10-20% in F of reproductive age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is endometriosis

A

Extrauterine endometrial stromal and glandular tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Theories on pathophysiology of endometriosis

A
  1. retorgrade menstruation
  2. coelomic metaplasia
  3. haematogenous or lymphatic dispersion
  4. immunological dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cyclical pattern of endometriosis

A

Respond to cyclical changes in oestrogen and progesterone.
Proliferation, shedding and bleeding.
In turn leads to inflammation, fibrosis, adhesions and scarring (and reportedly pelvic pain).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diseases which frequently co-exist with endometriosis

A

fibromyalgia, chronic fatigue syndrome, IBS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Symptoms of endometriosis

A

Incidental finding
Chronic or cyclical pelvic pain
Subfertility
Adnexal masses

18
Q

Managment of endometriosis

A

pharmacological - COCP, GnRH analogues, progestogen implant, pill or inj, Mirena, aromatase inhibitors (less common)
surgical treatment - after 3-6m trial of ovarian supression

19
Q

Prefered surgical managment of endometriosis

A

Excision if severe.
Alternative is ablation.
Cystectomy for endometrioma rather than aspiration.
Final option - TAH + BSO

20
Q

What does uterine artery embolisation involve

A

Minimally invasive occlusion of the uterine artery is with polyvinyl alcohol beads.
Transfemoral approach
Local anaesthetic and light sedation

21
Q

Causes of menorrhagia

A
40-60% no pathology
20% anovulatory cycle
Fibroids
Endometrial polyp
Endometriosis
Adenomyosis
Endometritis
PID
Endometrial hyperplasia
Endometrial carcinoma
Systemic disease-hypothyroidism, liver, kidney, obesity, von Willebrand disease
IUD
22
Q

Medical management of menorrhagia

A

Mirena -1st line

Tranexamic acid / Mefenamic acid / POP/COCP - 2nd line

23
Q

Types of eczema

A

Atopic - allergic
Allergic contact
Irritant contact

24
Q

Symptoms + signs of vulval eczema

A

Vulval Itch and soreness
Excoriation
Erythema, lichenification
Fissuring and pallor or hyperpigmentation

25
Q

Complications of vulval eczema

A

Secondary infection

26
Q

Management of vulval eczema

A
Avoid precipitant
Emollient
Emollient soap substitute
Topical corticosteroid
Combined antifungal +/- antibiotic if required
27
Q

Symptoms of vulval psoriasis

A

Itch, soreness and burning

28
Q

Signs of vulval psoriasis

A

Well demarcated Erythematous plaques
Often lacks scaling
Frequent in natal cleft
Fissuring

29
Q

Management of vulval psoriasis

A
Avoid irritating factors
Emollient
Topical corticosteroid
Week coal tar preparations
Vitamin D analogues
30
Q

Aetiology of VIN

A

May become cancerous if left untreated.
Can be HPV related - may resolve
May be lichen sclerosis or lichen planus related - higher risk of progression to SCC

31
Q

Symptoms of VIN

A

Lumps, erosions, burning, itch, irritation, pain

32
Q

Clinical appearance of V I N

A

Variable
Raised white, erythematous , pigmented
Lesions may be warty, moist, eroded
Multi focal lesions common

33
Q

Complications of VIN

A

Development of SCC
Recurrence
Psychosexual consequences

34
Q

Diagnosis of VIN

A

Biopsy

35
Q

Management of VIN

A
colposcopy
Cervical cytology up-to-date
Local excision
Imiquimod cream
Vulvectomy
36
Q

Follow-up of VIN

A

Vulval clinic

Close follow-up

37
Q

Most common type of cervical cancer

A

80% squamous cell carcinoma

20% adenocarcinoma

38
Q

Presentation of triple x (47XXX)

A
Female
1:1000
Neuromuscular delay
Developmental delay
Immature behaviour 
Reduced IQ
Tall
39
Q

Anovulation may be associated with what

8

A
Drugs including some contraception
Stress / depression
Excess exercise
Excess weight loss
Chronic renal failure
Asthma
PCOS
Cushing syndrome
40
Q
Normal ranges for:
Ostradiol 
LH
FSH
Prolactin 
Testosterone
A
Normal ranges for:
Ostradiol 130 - 830 pmol/L
LH 1-10 mu/L
FSH 1 -10 
Prolactin 50 - 450 U/L
Testosterone <3 pmol/L
41
Q

Common causes of PMB

A
Atrophy - 60%
Polyps - 12%
Endometrial cancer - 10%
Endometrial hyperplasia - 10%
Hormonal effect - 7%
Cervical cancer <1%